CONMED signed a definitive agreement to acquire SurgiQuest for $265 million on a cash-free, debt-free basis.
Spinal Tech
InVivo Therapeutics, based in Cambridge, Mass., plans to create Bioengineered Neural Trails to treat patients with chronic spinal injuries, according to the Boston Business Journal. The company already plans to treat patients with its spinal scaffold, a bioresorbable substance that…
On Dec. 1, Zacks downgraded Mazor Robotics shares to a "hold" rating, according to WKRB.
Cytos Biotechnology and Kuros Biosurgery intend to combine their business.
Xtant Medical, formerly known as Bacterin, announced its CFO John Gandolfo will present at the ICV Manhattan Conference.
Advertisement
InVivo Therapeutics has final plans for a pivotal study and a new licensing agreement.
Xtant Medical's subsidiary Bacterin developed a three-dimensional printer that can prototype custom, resorbable bone grafts for reconstructive procedures.
Amedica shares saw a significant 39.7 percent growth in short interest in November, according to a Dakota Financial News report.
The FDA's safety claim for Zimmer's injection indicates the product is safe to use in repeat treatments for knee osteoarthritis patients.
Patients in Michigan now have the option for a knee and/or hip surgery that is more accurate and requires less recovery time.